These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1858084)
1. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man. Spencer DA; Evans JM; Green SE; Piper PJ; Costello JF Thorax; 1991 Jun; 46(6):441-5. PubMed ID: 1858084 [TBL] [Abstract][Full Text] [Related]
2. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics. Joos GF; Kips JC; Pauwels RA; Van der Straeten ME Pulm Pharmacol; 1991; 4(1):37-42. PubMed ID: 1804493 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219. Kidney JC; Ridge SM; Chung KF; Barnes PJ Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421 [TBL] [Abstract][Full Text] [Related]
4. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. Taylor IK; Ward PS; Taylor GW; Dollery CT; Fuller RW J Appl Physiol (1985); 1991 Oct; 71(4):1396-402. PubMed ID: 1661723 [TBL] [Abstract][Full Text] [Related]
5. The pharmacological profile of SK&F 104353-Z2, a potent, selective inhaled antagonist of cysteinyl leukotrienes, in normal man. Evans JM; Piper PJ; Costello JF Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():469-72. PubMed ID: 1825584 [No Abstract] [Full Text] [Related]
6. Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. Chung KF; Barnes PJ Thorax; 1989 Feb; 44(2):108-15. PubMed ID: 2648646 [TBL] [Abstract][Full Text] [Related]
7. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. Lai CK; Jenkins JR; Polosa R; Holgate ST J Appl Physiol (1985); 1990 Mar; 68(3):919-26. PubMed ID: 2187854 [TBL] [Abstract][Full Text] [Related]
8. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man. Chung KF; Dent G; Barnes PJ Thorax; 1989 Feb; 44(2):102-7. PubMed ID: 2648645 [TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. Kaye MG; Smith LJ Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768 [TBL] [Abstract][Full Text] [Related]
11. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo. Robuschi M; Riva E; Fuccella LM; Vida E; Barnabe R; Rossi M; Gambaro G; Spagnotto S; Bianco S Am Rev Respir Dis; 1992 Jun; 145(6):1285-8. PubMed ID: 1595992 [TBL] [Abstract][Full Text] [Related]
12. The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways. Stenton SC; Ward C; Duddridge M; Harris A; Palmer JB; Hendrick DJ; Walters EH Clin Exp Allergy; 1990 May; 20(3):311-7. PubMed ID: 2142013 [TBL] [Abstract][Full Text] [Related]
13. The effect of inhalation of the leukotriene receptor antagonist, SK&F 104353, on leukotriene C4- and leukotriene E4-induced bronchoconstriction in subjects with asthma. Christie PE; Spur BW; Lee TH J Allergy Clin Immunol; 1991 Aug; 88(2):193-8. PubMed ID: 1652604 [TBL] [Abstract][Full Text] [Related]
14. Effects of SK&F 104353, a leukotriene receptor antagonist, on the bronchial responses to histamine in subjects with asthma: a comparative study with terfenadine. Dinh Xuan AT; Regnard J; Similowski T; Rey J; Marsac J; Lockhart A J Allergy Clin Immunol; 1990 May; 85(5):865-71. PubMed ID: 1970584 [TBL] [Abstract][Full Text] [Related]
15. L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man. Evans JM; Barnes NC; Zakrzewski JT; Sciberras DG; Stahl EG; Piper PJ; Costello JF Br J Clin Pharmacol; 1989 Aug; 28(2):125-35. PubMed ID: 2775617 [TBL] [Abstract][Full Text] [Related]
16. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Spring J; Johnston SR; Seale J; Ind PW Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250 [TBL] [Abstract][Full Text] [Related]
17. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Christie PE; Smith CM; Lee TH Am Rev Respir Dis; 1991 Oct; 144(4):957-8. PubMed ID: 1928974 [TBL] [Abstract][Full Text] [Related]
18. The bronchoconstrictor properties of platelet-activating factor in humans. Rubin AH; Smith LJ; Patterson R Am Rev Respir Dis; 1987 Nov; 136(5):1145-51. PubMed ID: 3314611 [TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. Echazarreta AL; Gómez FP; Ribas J; Achaval M; Barberà JA; Roca J; Chung KF; Rodriguez-Roisin R Eur Respir J; 1999 Sep; 14(3):616-21. PubMed ID: 10543284 [TBL] [Abstract][Full Text] [Related]
20. Effect of theophylline on airway responses to inhaled platelet-activating factor in man. Chung KF; Lammers JW; McCusker M; Roberts NM; Nichol GM; Barnes PJ Eur Respir J; 1989 Sep; 2(8):763-8. PubMed ID: 2680584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]